Job Description
Senior Manager Costing, MIS and Opex - CMA with 7-8 years experience
Costing Related activities
- Month close activities related to Costing, inventory and materials closing Prepare product sales, costing & gross margin analysis
- Further deep dive into material costs variance rate / usage / mix variance and actions to be taken to improve RM costs
- Support Site in month close and MIS finalisation
- Support site in annual budgeting activities and cost audit activities
- Support site in opex costs review and cost controls
- Work with operational excellence team on validating savings from solvent recovery, catalyst recovery, product yield improvements, purchase price variance (PPV) and productivity and efficiency excellence.
- Circulate monthly RM costs data to Production heads and discuss on rate / usage variances, as may be required
- Support site on various material costs automation initiatives
- Act as a SPOC for Site internal audits & insurance activities
Net Working Capital / Balance sheet activities
- Preparation of Forecast Net working capital and rolling forecast cash flows
- Review of Inventories Interact with Site Supply chain, program management, warehouse to achieve closure of old and aged items
- Preparation of Budget Balance Sheet (annual activity)
- Co-ordination with Corporate Finance teams for the annual/quarterly closing Material costs and inventory schedules
- Practical knowledge of Indian Accounting Standards (IND AS) relevant to the areas of Inventory
Qualifications
CMA with 7-8 years experience
Good cross functional communication skills
Good articulation and presentation skills
Should be able to take initiative and ownership of assigned tasks
About Us
In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth.
Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices.
Equal employment opportunity
Piramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer. We do not discriminate based upon race, ethnicity, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, genetics, or other applicable legally protected characteristics.
We base our employment decisions on merit considering qualifications, skills, performance, and achievements. We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters, including recruitment, selection, training, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions, including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice.
About The Team
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited's investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovators and generic companies worldwide.
